Guang-Jie Liu

Dr. Guang-Jie Liu


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2025 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Open access
GLGaofeng Liu
Gaofeng Liu
SKShanshan Kuang
Shanshan Kuang
WZWeixing Zhong
Weixing Zhong
AYAnming Yang
Anming Yang
XHXiaoli Huang
Xiaoli Huang
GLGuang-Jie Liu
Guang-Jie Liu
This study systematically predicts the active components, targets, and mechanisms of JLZP against HCC by integrating LC-MS, network pharmacology, and molecular docking, with experimental validation of its pro-pyroptotic effects. Through HERB and NPASS databases, 81 bioactive components of JLZP and 78 overlapping HCC-related targets were identified. Protein-protein interaction network and KEGG enrichment analyses revealed that JLZP likely induces cell death via cancer-related pathways. Molecular docking (CB-Dock2) demonstrated high binding affinity between JLZP core components (e.g., protopine) and pyroptosis-associated targets (NLRP3, GSDMD). In vitro experiments confirmed that JLZP significantly suppressed MHCC-97L cell proliferation and migration, while upregulating pyroptosis markers (IL-1β, IL-18) at both mRNA and protein levels, with these effects reversed by a pyroptosis inhibitor. This study is the first to elucidate JLZP's anti-HCC mechanism through pyroptosis activation, identifying its pharmacodynamic material basis and multi-target action. The "component-target-pathway-experiment" multidimensional strategy provides methodological insights for deciphering traditional Chinese medicine formulas, offering a theoretical foundation for developing JLZP-based anticancer therapies.

19 June 2024 in International Journal of Surgery
Verified
Journal Article
Open access
TLTianhua Li
Tianhua Li
RYRenjie Yang
Renjie Yang
JWJie Wang
Jie Wang
TWTao Wang
Tao Wang
GLGuang-Jie Liu
Guang-Jie Liu
LJLiqun Jiao
Liqun Jiao
Background: Silent cerebral infarction (SCI) that manifests following carotid artery stenting (CAS) has been postulated to correlate with cognitive decline, the onset of dementia, and an increased risk of subsequent cerebrovascular events. This investigation aimed to thoroughly examine the potential anatomical predispositions that are linked to the occurrence of SCI post-CAS, and further develop a predictive nomogram that could accurately forecast the risk of SCI post-CAS. Methods: The present investigation conducted a retrospective examination of datasets from 250 individuals presenting with carotid artery stenosis who had been subjected to CAS within a tertiary healthcare institution from June 2020 to November 2021. Stratified by the procedural date, participants were allocated into a training cohort and a validation cohort. A nomogram was constructed predicated on salient prognostic determinants discerned via a multivariate logistic regression analysis. Results: An aggregate of 184 patients were incorporated into the study, of which 60 (32.6%) manifested SCI, whereas 124 (67.4%) did not. Within the training cohort (n=123), age (OR 1.08, 95% CI: 1.01–1.16; P=0.034), aortic arch type (Type III vs. I: OR 10.79, 95% CI: 2.12–54.81; P=0.005), aortic arch variant (OR 47.71, 95% CI: 6.05–376.09; P<0.001), common carotid artery (CCA) ostium lesions (OR 6.93, 95% CI: 1.49–32.32; P=0.014), and proximal tortuosity index (TI) (OR 1.01, 95% CI: 1.00–1.02; P=0.029) were demarcated as standalone risk predispositions for SCI subsequent to CAS. The concordance index (C-index) for the training cohort's nomogram stood at 0.89 (95% CI: 0.84–0.95). Moreover, the said nomogram exhibited commendable efficacy within the validation cohort (C-index=0.94) as well as the entire participant base (C-index=0.90). Furthermore, the decision curve analysis illustrated the exemplary clinical applicability of the nomogram. Conclusions: The findings of this inquiry underscore that age, aortic arch type, aortic arch variant, CCA ostium lesions, and proximal TI serve as independent determinants linked with SCI post-CAS. The formulated nomogram, predicated on these risk factors, possesses robust prognostic significance, and might serve as a valuable adjunct to inform clinical decision-making.

17 December 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
GLGaofeng Liu
Gaofeng Liu
QQQingguang Qin
Qingguang Qin
WZWeixing Zhong
Weixing Zhong
HLHongwen Liu
Hongwen Liu
YXYin Xie
Yin Xie
YLYikai Li
Yikai Li
Intervertebral disc degeneration (IDD) severely impacts patients’ quality of life. Elucidating IDD’s molecular mechanisms is crucial for developing effective diagnostics and therapeutics. Integrating multiple IDD gene expression datasets using bioinformatics identified 25 glycosylation-related differentially expressed genes (GRDEGs). We analyzed their biological functions and regulatory networks in IDD using GO, KEGG, GSEA, and WGCNA. An IDD diagnostic LASSO regression model was constructed and validated. Immune cell infiltration analysis using CIBERSORT/ssGSEA divided IDD samples into subtypes based on glycosylation scores, exploring the immune microenvironment’s influence on heterogeneity. We explored regulatory networks involving transcription factors, miRNAs, RNA-binding proteins, and drugs affecting key genes. 25 GRDEGs were identified from 625 glycosylation-related genes (GRGs), and 9 hub genes were further screened by WGCNA to clarify their biological functions and regulatory networks. The diagnostic model based on 7 key genes performed well in the training and validation sets. In addition, Spearman correlation analysis showed that 6 key genes (MAN2B2, MAN1A1, CHI3L1, PLOD2, RAPGEF5, GLA) were significantly associated with immune cell infiltration, including Eosinophils, Dendritic cells, Macrophages M0, and T regulatory cells. Three key genes (MAN2B2, GLA, CHI3L1) significantly affected the differences between high and low glycosylation score subtypes in the immune microenvironment. In addition, regulatory networks, including 49 transcription factors, 32 miRNAs, 116 RNA-binding proteins, and 20 potential drugs, were identified. This study explored the characteristics of glycosylation-related genes in IDD and their potential association with immune infiltration, providing preliminary insights that may inform future research on diagnostic biomarkers and therapeutic targets.